Ignite Creation Date:
2025-12-24 @ 9:26 PM
Ignite Modification Date:
2025-12-29 @ 12:02 PM
Study NCT ID:
NCT01805232
Status:
UNKNOWN
Last Update Posted:
2013-03-06
First Post:
2013-03-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intravenous Artesunate and Malaria
Sponsor:
University of Khartoum
Organization:
Study Overview
Official Title:
Intravenous Artesunate Versus Quinine in Severe Malaria at Kassla, Sudan
Status:
UNKNOWN
Status Verified Date:
2013-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IVAS
Brief Summary:
Intravenous artesunate is egual to quinine in the treatment of severe malaria
Detailed Description:
Intravenous artesunate is egual to quinine in the treatment of severe malaria in the form of fever clearance time and parasite clearance time
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: